15 Apr 2016 07:00
RNS Number : 2799V
Port Erin Biopharma Investments Ltd
15 April 2016
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Change of Adviser
The Board of Port Erin, the AIM quoted company focused on investing in the biotechnology and biopharmaceutical sectors, is pleased to announce the appointment of Northland Capital Partners Limited as the Company's Nominated Adviser and Joint Broker with immediate effect.
Enquiries
Port Erin Biopharma Investments Limited | +44(0) 1624 639396 |
Denham Eke |
|
|
|
Northland Capital Partners Limited | +44(0) 203 861 6625 |
Nominated Adviser and Joint Broker |
|
Matthew Johnson / David Hignell / Gerry Beaney (Corporate Finance) |
|
John Howes / Rob Rees (Broking) |
|
|
|
Peterhouse Corporate Finance Limited | +44(0) 207 469 0936 |
Joint Broker |
|
Lucy Williams |
|
This information is provided by RNS
The company news service from the London Stock Exchange
Agronomics (ANIC)